Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (461-470 of 683) with videos related to

Pageof 69
Sort By:
Critical Care Medicine|November 9, 2017
Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-AnalysisNathaniel J Rhodes, Jiajun Liu, J Nicholas O'Donnell, et al.
International Journal of Antimicrobial Agents|January 9, 2022
Innovation in microsampling for therapeutic drug monitoring of gentamicin in neonates: a proof-of-concept studySuzanne L Parker, Adam D Irwin, Francine Hosking, et al.
Analytical and Bioanalytical Chemistry|January 4, 2022
Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samplesSuzanne L Parker, Steven C Wallis, Cheryl Fourie, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2022
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolatesChandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2023
Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteriaDaniel Fresán, Sonia Luque, Adela Benítez-Cano, et al.
The Lancet. Infectious Diseases|June 22, 2023
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infectionNoé Brasier, H Ceren Ates, Juliane R Sempionatto, et al.
Intensive Care Medicine|August 23, 2022
Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing softwareJason A Roberts, Rinaldo Bellomo, Menino O Cotta, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021Maggie M Chau, Kathryn Daveson, Jan-Willem C Alffenaar, et al.
Anaesthesia, Critical Care & Pain Medicine|October 31, 2025
Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgeryVesa Cheng, Jessica Suna, Xin Liu, et al.
Critical Care (London, England)|May 7, 2013
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Sofie Carrette, Jason A Roberts, et al.
Pageof 69

Showing results (461-470 of 683) with videos related to

Sort By:
Pageof 69
Critical Care Medicine|November 9, 2017
Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-AnalysisNathaniel J Rhodes, Jiajun Liu, J Nicholas O'Donnell, et al.
International Journal of Antimicrobial Agents|January 9, 2022
Innovation in microsampling for therapeutic drug monitoring of gentamicin in neonates: a proof-of-concept studySuzanne L Parker, Adam D Irwin, Francine Hosking, et al.
Analytical and Bioanalytical Chemistry|January 4, 2022
Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samplesSuzanne L Parker, Steven C Wallis, Cheryl Fourie, et al.
The Journal of Antimicrobial Chemotherapy|August 29, 2022
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolatesChandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, et al.
The Journal of Antimicrobial Chemotherapy|October 12, 2023
Real-world experience of therapeutic drug monitoring and PK/PD achievement of ceftaroline administered by different infusion regimens in patients with confirmed infections caused by Gram-positive bacteriaDaniel Fresán, Sonia Luque, Adela Benítez-Cano, et al.
The Lancet. Infectious Diseases|June 22, 2023
A three-level model for therapeutic drug monitoring of antimicrobials at the site of infectionNoé Brasier, H Ceren Ates, Juliane R Sempionatto, et al.
Intensive Care Medicine|August 23, 2022
Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing softwareJason A Roberts, Rinaldo Bellomo, Menino O Cotta, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021Maggie M Chau, Kathryn Daveson, Jan-Willem C Alffenaar, et al.
Anaesthesia, Critical Care & Pain Medicine|October 31, 2025
Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgeryVesa Cheng, Jessica Suna, Xin Liu, et al.
Critical Care (London, England)|May 7, 2013
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?Mieke Carlier, Sofie Carrette, Jason A Roberts, et al.
Pageof 69